Las Vegas, NV -- (SBWIRE) -- 12/13/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: Crestwood Midstream Partners LP(NYSE:CMLP), Celsion Corporation (NASDAQ:CLSN), Camtek LTD.(NASDAQ:CAMT), AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO)
Crestwood Midstream Partners LP(NYSE:CMLP) increased 5.25% at the price of $22.47 recently on a traded volume 1.77 million shares, in comparison to 605,704.00 shares of average trading volume. So far this year, the stock is up over 0.9%.
The company has a total market capitalization of $3.96 billion and its total outstanding shares are 176.34 million. Crestwood Midstream Partners LP is a master limited partnership. The Company owns and operates midstream businesses in multiple unconventional shale resource plays across the United States. In November 2013, the Company announced that it has completed the acquisition of Arrow Midstream Holdings, LLC, a privately-held midstream company.
For How Long CMLP will Fight for Profitability? Read This Trend Analysis report
Celsion Corporation (NASDAQ:CLSN) soared 15.38% at the trading price of $4.10 on a traded volume of 3.34 million shares till now, whereas its average trading volume is 344,762.00 shares. In the last three months, the stock is up 240%. The Intra-day range for the stock is $4.05 and $4.59. Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study).
For How Long CLSN Gloss will Attract Investors? Find out via this report
Camtek LTD.(NASDAQ:CAMT) jumped up 17.83% at the $4.17 recently. So far in three months, the stock is up 147.72%. The 52-week range for the stock is $1.31 and $6.43. Its introductory price for the day was $3.80, with the overall traded volume of 3.53 million shares. Camtek Ltd. (Camtek) designs, develops, manufactures and markets automated solutions dedicated for enhancing production processes and yield for the semiconductor manufacturing and packaging and the printed circuit board (PCB) and integrated circuit (IC) substrate industries.
Will CAMT Continue To Move Higher? Find Out Here
AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO), after opening its shares at the price of $1.80, dropped -12.63% , its recent trading price was $1.64 for the day. The stock moved on a traded volume of 2.63 million shares, in comparison to 586,492.00 shares of average trading volume.
The 52-week range for the stock is $1.53 and $8.94. Its introductory price for the day was $1.80. AVEO Pharmaceuticals, Inc. is a cancer therapeutics company discovering, developing and commercializing targeted cancer therapies. The Company’s Human Response Platform, a method of building preclinical models of human cancer, provides the Company with insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics.
Will AVEO Get Buyers Even After The Recent Rally? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)